GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 14, Pages 1748-1757
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-04-09
DOI
10.1200/jco.2012.43.1882
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
- (2013) Rosalind A Eeles et al. NATURE GENETICS
- Germline BRCA1 mutations increase prostate cancer risk
- (2012) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities
- (2011) Naomi Williams et al. BJU INTERNATIONAL
- Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer
- (2011) David J. Gallagher et al. BJU INTERNATIONAL
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families
- (2011) Heather Thorne et al. Cancer Prevention Research
- Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer
- (2011) Matthias M. Heck et al. EUROPEAN JOURNAL OF CANCER
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
- (2010) Anita V. Mitra et al. BJU INTERNATIONAL
- Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
- (2010) S M Edwards et al. BRITISH JOURNAL OF CANCER
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
- (2010) Jonas Hugosson et al. LANCET ONCOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
- (2008) A Mitra et al. BRITISH JOURNAL OF CANCER
- Rapid progression of prostate cancer in men with a BRCA2 mutation
- (2008) S A Narod et al. BRITISH JOURNAL OF CANCER
- Diagnosis and treatment of prostate cancer: summary of NICE guidance
- (2008) John Graham et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search